Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 42.07
- Piotroski Score 1.00
- Grade Buy
- Symbol (EYES)
- Company Second Sight Medical Products, Inc.
- Price $4.14
- Changes Percentage (-5.05%)
- Change -$0.22
- Day Low $4.14
- Day High $4.35
- Year High $0.00
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 07/04/2022
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio 0
- Forward P/E Ratio 0
- P/E Growth 0
- Net Income $-8,933,000
Income Statement
Quarterly
Annual
Latest News of EYES
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Bitcoin Eyes Acceptance Above 200-day MA as ETF Flows Remain Positive
Bitcoin is on the verge of a bullish breakout with a potential rise above the 200-day MA and $65k. Positive ETF flows and growing optimism hint at further gains. However, failure to break above may le...
By Yahoo! Finance | 3 days ago -
Jets, Sauce Gardner have eyes on Broncos' $96M man Patrick Surtain
Two star cornerbacks, Sauce Gardner and Patrick Surtain II, will face off at MetLife Stadium. Gardner admires Surtain's career and recent big contract. Despite Gardner's bright future, he remains focu...
By New York Post | 4 days ago -
Finland's Orion eyes US sales boost with blockbuster prostate cancer drug
Finnish drugmaker Orion aims to increase sales in the U.S. with its prostate cancer drug Nubeqa. Developed with Bayer, the drug has achieved over a billion euros in sales this year, prompting expansio...
By Yahoo! Finance | 4 days ago